Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    biopure OR polyheme OR oxycyte OR hemolink OR stanate | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Available Compassionate Use of Stanate (TM) [Stannsoporfin]
Conditions: Neonatal Jaundice;   Hyperbilirubinemia
Intervention: Drug: Stanate (TM) [stannsoporfin, tin-mesoporphyrin]

Study has passed its completion date and status has not been verified in more than two years.